Search

Your search keyword '"Visser, G H"' showing total 919 results
Start Over Author "Visser, G H"
919 results on '"Visser, G H"'

9. European consensus guidelines on the management of respiratory distress syndrome:2022 update

Author

Sweet, D. G. (David G.), Carnielli, V. P. (Virgilio P.), Greisen, G. (Gorm), Hallman, M. (Mikko), Klebermass-Schrehof, K. (Katrin), Ozek, E. (Eren), te Pas, A. (Arjan), Plavka, R. (Richard), Roehr, C. C. (Charles C.), Saugstad, O. D. (Ola D.), Simeoni, U. (Umberto), Speer, C. P. (Christian P.), Vento, M. (Maximo), Visser, G. H. (Gerry H.A.), Halliday, H. L. (Henry L.), Sweet, D. G. (David G.), Carnielli, V. P. (Virgilio P.), Greisen, G. (Gorm), Hallman, M. (Mikko), Klebermass-Schrehof, K. (Katrin), Ozek, E. (Eren), te Pas, A. (Arjan), Plavka, R. (Richard), Roehr, C. C. (Charles C.), Saugstad, O. D. (Ola D.), Simeoni, U. (Umberto), Speer, C. P. (Christian P.), Vento, M. (Maximo), Visser, G. H. (Gerry H.A.), and Halliday, H. L. (Henry L.)

Abstract

Respiratory distress syndrome (RDS) care pathways evolve slowly as new evidence emerges. We report the sixth version of “European Guidelines for the Management of RDS” by a panel of experienced European neonatologists and an expert perinatal obstetrician based on available literature up to end of 2022. Optimising outcome for babies with RDS includes prediction of risk of preterm delivery, appropriate maternal transfer to a perinatal centre, and appropriate and timely use of antenatal steroids. Evidence-based lung-protective management includes initiation of non-invasive respiratory support from birth, judicious use of oxygen, early surfactant administration, caffeine therapy, and avoidance of intubation and mechanical ventilation where possible. Methods of ongoing non-invasive respiratory support have been further refined and may help reduce chronic lung disease. As technology for delivering mechanical ventilation improves, the risk of causing lung injury should decrease, although minimising time spent on mechanical ventilation by targeted use of postnatal corticosteroids remains essential. The general care of infants with RDS is also reviewed, including emphasis on appropriate cardiovascular support and judicious use of antibiotics as being important determinants of best outcome. We would like to dedicate this guideline to the memory of Professor Henry Halliday who died on November 12, 2022.These updated guidelines contain evidence from recent Cochrane reviews and medical literature since 2019. Strength of evidence supporting recommendations has been evaluated using the GRADE system. There are changes to some of the previous recommendations as well as some changes to the strength of evidence supporting recommendations that have not changed. This guideline has been endorsed by the European Society for Paediatric Research (ESPR) and the Union of European Neonatal and Perinatal Societies (UENPS).

Published
2023

10. Antenatal corticosteroids and perinatal outcome in late fetal growth restriction: analysis of prospective cohort

Author

Familiari, Alessandra, Napolitano, R, Visser, G H A, Lees, C, Wolf, H, Prefumo, F, Familiari, A (ORCID:0000-0002-6353-9383), Familiari, Alessandra, Napolitano, R, Visser, G H A, Lees, C, Wolf, H, Prefumo, F, and Familiari, A (ORCID:0000-0002-6353-9383)

Abstract

Objective To evaluate the role of antenatal administration of corticosteroids for fetal lung maturation on the short-term perinatal outcome of pregnancy complicated by late fetal growth restriction (FGR).Methods This cohort study was a secondary analysis of a multicenter prospective observational study, the TRUFFLE-2 feasibility study, conducted between 2017 and 2018 in 33 European perinatal centers. The study included women with a singleton pregnancy from 32 + 0 to 36 + 6 weeks of gestation with a fetus considered at risk for FGR, defined as estimated fetal weight (EFW) and/or fetal abdominal circumference < 10(th) percentile, or umbilicocerebral ratio (UCR) >= 95(th) percentile or a drop of more than 40 percentile points in abdominal circumference measurement from the 20-week scan. For the purposes of the current study, we identified women who received a single course of steroids to improve fetal lung maturation before delivery. Each exposed pregnancy was matched with one that did not receive antenatal corticosteroids (ACS) (control), based on gestational age at delivery and birth weight. The primary adverse outcome was a composite of abnormal condition at birth, major neonatal morbidity or perinatal death.Results A total of 86 pregnancies that received ACS were matched to 86 controls. The two groups were similar with respect to gestational age (33.1 vs 33.3 weeks), EFW (1673 vs 1634 g) and UCR (0.68 vs 0.62) at inclusion, and gestational age at delivery (35.5 vs 35.9 weeks) and birth weight (1925 vs 1948 g). No significant differences were observed between the exposed and non-exposed groups in the incidence of composite adverse outcome (28% vs 24%; P = 0.73) or any of its elements.Conclusion The present data do not show a beneficial effect of steroids on short-term outcome of fetuses with late FGR.

Published
2023

14. Antenatal corticosteroids and perinatal outcome in late fetal growth restriction: analysis of prospective cohort.

Author

Familiari, A., Napolitano, R., Visser, G. H. A., Lees, C., Wolf, H., Prefumo, F., Arabin, B., Berger, A., Bergman, E., Bhide, A., Bilardo, C. M., Breeze, A. C., Brodszki, J., Calda, P., Cesari, E., Cetin, I., Derks, J. B., Ebbing, C., Ferrazzi, E., and Frusca, T.

Subjects
FETAL growth retardation, PREGNANCY outcomes, COHORT analysis, GESTATIONAL age, BIRTH weight, FETAL anoxia
Abstract

Objective: The aim of this study is to evaluate the possible role of antenatal administration of corticosteroids for fetal lung maturation on short term perinatal outcomes in late FGR.Methods: This cohort study is a secondary analysis of a multicenter prospective observational study, the TRUFFLE-2 feasibility study, conducted between 2017 and 2018 in 33 European perinatal centers. We included women with singleton pregnancy from 32+0 to 36+6 weeks of gestation with a fetus considered at risk for FGR, defined as estimated fetal weight (EFW) or abdominal circumference (AC) <10th centile, or umbilico-cerebral ratio (UCR) >95th centile, or a fall of more than 40 centile points in AC measurement from the 20 weeks scan. The primary adverse outcome was a composite of abnormal condition at birth or major neonatal morbidity.Results: A total of 86 pregnancies who received antenatal corticosteroids (exposed) were matched with non-exposed pregnancies. Both groups were similar regarding gestational age at inclusion (33 weeks), EFW (1673 g) and UCR (0.68), gestational age at delivery (35.5 weeks) and birth weight (1925 g); the presented values are for both groups combined. No significant differences were observed between exposed and non-exposed for composite adverse outcome (28% vs. 24%; p=0.73) or for any of its elements.Conclusion: The present data do not show a beneficial effect of steroids on short term outcomes in fetuses with late FGR. This article is protected by copyright. All rights reserved. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

18. Fetal cerebral Doppler changes and outcome in late preterm fetal growth restriction : prospective cohort study

Author

Stampalija, T., Thornton, J., Marlow, N., Napolitano, R., Bhide, A., Pickles, T., Bilardo, C. M., Gordijn, S. J., Gyselaers, W., Valensise, H., Hecher, K., Sande, R. K., Lindgren, P., Bergman, E., Arabin, B., Breeze, A. C., Wee, L., Ganzevoort, W., Richter, J., Berger, A., Brodszki, J., Derks, J., Mecacci, F., Maruotti, G. M., Myklestad, K., Lobmaier, S. M., Prefumo, F., Klaritsch, P., Calda, P., Ebbing, C., Frusca, T., Raio, L., Visser, G. H. A., Krofta, L., Cetin, I., Ferrazzi, E., Cesari, E., Wolf, H., Lees, C. C., Brezinka, C., Casagrandi, D., Cerny, A., Dall'Asta, A., Devlieger, R., Duvekot, J., Eggebo, T. M., Fantasia, I., Ferrari, F., Fratelli, N., Ghi, T., Graupner, O., Greimel, P., Hofstaetter, C., Presti, D. Lo, Georg, M., Macsali, F., Marsal, K., Martinelli, P., Mylrea-Foley, B., Mullins, E., Ostermayer, E., Papageorghiou, A., Peasley, R., Ramoni, A., Sarno, L., Seikku, L., Simeone, S., Thilaganathan, B., Tiralongo, G., Valcamonico, A., van Holsbeke, C., Vietheer, A., APH - Quality of Care, ARD - Amsterdam Reproduction and Development, Obstetrics and Gynaecology, APH - Digital Health, Stampalija, T., Thornton, J., Marlow, N., Napolitano, R., Bhide, A., Pickles, T., Bilardo, C. M., Gordijn, S. J., Gyselaers, W., Valensise, H., Hecher, K., Sande, R. K., Lindgren, P., Bergman, E., Arabin, B., Breeze, A. C., Wee, L., Ganzevoort, W., Richter, J., Berger, A., Brodszki, J., Derks, J., Mecacci, F., Maruotti, G. M., Myklestad, K., Lobmaier, S. M., Prefumo, F., Klaritsch, P., Calda, P., Ebbing, C., Frusca, T., Raio, L., Visser, G. H. A., Krofta, L., Cetin, I., Ferrazzi, E., Cesari, E., Wolf, H., Lees, C. C., Brezinka, C., Casagrandi, D., Cerny, A., Dall'Asta, A., Devlieger, R., Duvekot, J., Eggebo, T. M., Fantasia, I., Ferrari, F., Fratelli, N., Ghi, T., Graupner, O., Greimel, P., Hofstaetter, C., Presti, D. L., Georg, M., Macsali, F., Marsal, K., Martinelli, P., Mylrea-Foley, B., Mullins, E., Ostermayer, E., Papageorghiou, A., Peasley, R., Ramoni, A., Sarno, L., Seikku, L., Simeone, S., Thilaganathan, B., Tiralongo, G., Valcamonico, A., Van Holsbeke, C., Vietheer, A., and HUS Gynecology and Obstetrics

Subjects
Technology, adverse outcome, umbilical-cerebral ratio, Umbilical Arteries, umbilical artery, TRUFFLE-2 Group, Fetal Development, 0302 clinical medicine, Obstetrics and gynaecology, Pregnancy, Reference Values, 3123 Gynaecology and paediatrics, Interquartile range, Birth Weight, Prospective Studies, 030212 general & internal medicine, Prospective cohort study, Fetal Growth Retardation, 030219 obstetrics & reproductive medicine, Radiological and Ultrasound Technology, Obstetrics, Radiology, Nuclear Medicine & Medical Imaging, Doppler, Obstetrics & Gynecology, Obstetrics and Gynecology, Gestational age, General Medicine, Stillbirth, 3. Good health, ddc, Europe, Fetal Weight, Pulsatile Flow, Infant, Small for Gestational Age, Female, Waist Circumference, Rheology, Life Sciences & Biomedicine, Live Birth, middle cerebral artery, neonatal, umbilicocerebral ratio, Radiology, Nuclear Medicine and Medical Imaging, Adult, medicine.medical_specialty, Birth weight, education, 610 Medicine & health, Gestational Age, Reproduktionsmedicin och gynekologi, DIAGNOSIS, Ultrasonography, Prenatal, 03 medical and health sciences, Fetus, Obstetrics, Gynecology and Reproductive Medicine, medicine, MANAGEMENT, Humans, Radiology, Nuclear Medicine and imaging, Risk factor, Obstetrics & Reproductive Medicine, Science & Technology, business.industry, CEREBROPLACENTAL RATIO, Infant, Newborn, Ultrasonography, Doppler, Acoustics, Reproductive Medicine, Relative risk, 1114 Paediatrics and Reproductive Medicine, Radiologi och bildbehandling, business
Abstract

OBJECTIVES: To explore the association between fetal umbilical and middle cerebral artery (MCA) Doppler abnormalities and outcome in late preterm pregnancies at risk of fetal growth restriction. METHODS: This was a prospective cohort study of singleton pregnancies at risk of fetal growth restriction at 32 + 0 to 36 + 6 weeks of gestation, enrolled in 33 European centers between 2017 and 2018, in which umbilical and fetal MCA Doppler velocimetry was performed. Pregnancies were considered at risk of fetal growth restriction if they had estimated fetal weight and/or abdominal circumference (AC)

Published
2020
Full Text
View/download PDF

19. Rapid target allopurinol concentrations in the hypoxic fetus after maternal administration during labour

Author

Kaandorp, J J, van den Broek, M P H, Benders, M J N L, Oudijk, M A, Porath, M M, Bambang Oetomo, S, Wouters, M G A J, van Elburg, Ruurd, Franssen, M T M, Bos, A F, Mol, B W J, Visser, G H A, van Bel, F, Rademaker, C M A, Derks, J B, de Haan, TR, Boon, J, de Boer, IP, Rijnders, RJP, Jacobs, CJWFM, Scheepers, HCJ, Gavilanes, AW, Bloemenkamp, KWM, Rijken, M, van Meir, CA, von Lindern, JS, Huisjes, AJM, and Bakker, CMJER

Published
2014
Full Text
View/download PDF

24. Critical umbilical artery Doppler abnormalities in early fetal growth restriction and the timing of delivery: an overestimated clinical challenge in daily obstetric practice?

Author

Lees, C., Marlow, N., Arabin, B., Bilardo, C. M., Brezinka, C., Derks, J. B., Duvekot, J., Frusca, T., Diemert, A., Ferrazzi, E., Ganzevoort, W., Hecher, K., Martinelli, P., Ostermayer, E., Papageorghiou, A. T., Schlembach, D., Schneider, K. T., Thilaganathan, B., Todros, T., van Wassenaer-Leemhuis, A., Valcamonico, A., Visser, G. H., and Wolf, H.

Published
2014
Full Text
View/download PDF

26. Automated Neonatal Brain Monitoring

Author

De Vos, M., primary, Cherian, P. J., additional, Deburchgraeve, W., additional, Swarte, R. M., additional, Govaert, P., additional, Van Huffel, S., additional, and Visser, G. H., additional

Published
2012
Full Text
View/download PDF

29. Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE)

Author

Lees, C., Marlow, N., Arabin, B., Bilardo, C. M., Brezinka, C., Derks, J. B., Duvekot, J., Frusca, T., Diemert, A., Ferrazzi, E., Ganzevoort, W., Hecher, K., Martinelli, P., Ostermayer, E., Papageorghiou, A. T., Schlembach, D., Schneider, K. T. M., Thilaganathan, B., Todros, T., van Wassenaer-Leemhuis, A., Valcamonico, A., Visser, G. H. A., Wolf, H., Scheepers, H. C. J., Spaanderman, M., Calvert, S., Missfelder-Lobos, H., van Eyck, J., Oepkes, D., Fratelli, N., Prefumo, F., Napolitano, R., Chaoui, R., Maso, G., Ogge, G., Oberto, M., and van Charante, Mensing N.

Published
2013
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results